Cat. No. | Product name | CAS No. | Purity | Chemical Structure |
---|---|---|---|---|
T34295 | Resiniferatoxin | 57444-62-9 | 98% |
|
Resiniferatoxin ([3H]resiniferatoxin) inhibits the production of Th1 cytokines, contributing to the defense against T. spiralis infection, and can be used in stu... | ||||
T1347 | 2-Benzothiazolamine | 136-95-8 | 98% |
|
2-Benzothiazolamine (2-ABT) is a nitrogen-containing heterocyclic compound used as a reaction intermediate in the synthesis of a variety of drugs. It inhibits cy... | ||||
TN4379 | Kansuinine A | 57701-86-7 | 98% |
|
Kansuinine A possesses analgesic props, it also shows NGF inducing activity. | ||||
TN1493 | Chrysosplenol D | 14965-20-9 | 98% |
|
Chrysosplenol D, an efflux pump inhibitor that can potentiate the activity of commercially important antibiotics and antimalarials. | ||||
T73689 | Daclizumab | 152923-56-3 | 98% |
Daclizumab
|
Daclizumab (Zenapax) is a humanized monoclonal antibody that specifically inhibits the alpha subunit of IL-2R-HA. Daclizumab (Zenapax) can inhibit the binding of... | ||||
T73695 | Canakinumab | 914613-48-2 | 98% |
|
Canakinumab (ACZ885) is a recombinant human IL-1β-targeting monoclonal antibody.Canakinumab has been shown to inhibit human and chorioallantoic monkey IL-1β, wit... | ||||
T75174 | Anti-inflammatory agent 42 | 877468-30-9 | 98% |
|
Anti-inflammatory agent 42 has anti-inflammatory activity and inhibits the expression of TNF-α and IL-6 in LPS-stimulated macrophages. | ||||
T76704 | Tralokinumab | 1044515-88-9 | 98% |
Tralokinumab
|
Tralokinumab is a fully human IgG4 monoclonal antibody with a high affinity for IL-13 alone. Tralokinumab's potential anti-inflammatory activity prevents IL-13 r... | ||||
T76722 | Sarilumab | 1189541-98-7 | 98% |
|
Sarilumab (SAR-153191)is a potent interleukin-6 IL-6 receptor antagonist and a human immunoglobulin G1 monoclonal antibody. Sarilumab inhibits IL-6-mediated sign... | ||||
T76744 | Enokizumab | 909875-08-7 | 98% |
Enokizumab
|
Enokizumab (MEDI-528) is a monoclonal antibody against interleukin IL-9. Enokizumab can be used to study asthma. | ||||
T76773 | Rolinsatamab | 2095467-30-2 | 98% |
Rolinsatamab
|
Rolinsatamab is a fully humanized selective monoclonal antibody that is a potent dual inhibitor of IL-4 and IL-13. Rolinsatamab chimeric antigen receptor sequenc... | ||||
T76777 | Bermekimab | 1401965-15-8 | 98% |
|
Bermekimab (MABp1) is a humanized monoclonal antibody against interleukin-1α (IL-1α).Bermekimab has potential anti-inflammatory activity to prevent skin inflamma... | ||||
T76778 | Risankizumab | 1612838-76-2 | 98% |
|
Risankizumab (BI 655066) is a humanized IgG monoclonal antibody (Kd <10 pM) targeting the IL-23 p19 subunit. Risankizumab inhibits IL-17 production induced by hu... | ||||
T76779 | Brodalumab | 1174395-19-7 | 98% |
|
Brodalumab (AMG 827) is a human monoclonal antibody targeting interleukin 17 receptor (IL-17R) IgG2, often used as an immunosuppressant in the treatment of psori... | ||||
T76784 | Tildrakizumab | 1326244-10-3 | 98% |
Tildrakizumab
|
Tildrakizumab (SCH 900222) is a potent humanized monoclonal antibody against IL-23 (p19 subunit). Tildrakizumab targets single-stranded IL-23 with a Kd value of ... | ||||
T76873 | Nidanilimab | 2171061-85-9 | 98% |
Nidanilimab
|
Nidanilimab (CAN04) is a fully humanized IL1RAP monoclonal antibody with a Kd value of 1.10 pM. Nidanilimab has antitumor activity, cutting off the IL1α and IL1β... | ||||
T76884 | Spesolimab | 2097104-58-8 | 98% |
Spesolimab
|
Spesolimab (BI 655130) is an anti-interleukin-36 receptor antibody. IL-36 plays an important role in the immune system and is associated with a reduction in biom... | ||||
T76892 | Ordesekimab | 879293-15-9 | 98% |
Ordesekimab
|
Ordesekimab (AMG 714) is a human IgG1 κ-anti-IL-15 (Interleukin Related) monoclonal antibody. Ordesekimab binds competitively to IL-15, inhibiting the interactio... | ||||
T76896 | Abrezekimab | 2043952-59-4 | 98% |
Abrezekimab
|
Abrezekimab (VR 942) is composed of CDP7766, leucine, and trehalose. Abrezekimab is a humanized antibody that targets human IL-13. Abrezekimab inhibits binding t... | ||||
T76978 | Siltuximab | 541502-14-1 | 98% |
Siltuximab
|
Siltuximab(CNTO-328) is a monoclonal antibody with anti-tumor activity targeting IL-6 for the study of giant lymph node hyperplasia (MCD) and COVID-19. |